EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist

Guodong Li, Ruoxin Du, Donghui Wang, Xiangmei Zhang, Lizhuo Wang, Shuangpeng Pu, Xiaoju Li, Shuning Wang, Juliang Zhang, Beichen Liu, Yuan Gao iD, Huadong Zhao

Advanced Science · 2025-04 · 12 (14)

DOI: 10.1002/advs.202409835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.01.2025. Verfasst von Guodong Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Biotechnology Center, School of Pharmacy, The Fourth Military Me…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Mitophagy, Immunotherapy, Adoptive, Hydrogels. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shaanxi Science Fund for Distinguished Young Scholars, Nation Nature Science Foundation of China, Xijing Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Leaky and structurally abnormal blood vessels and increased pressure in the tumor interstitium reduce the infiltration of CAR‐T cells in solid tumors, including triple‐negative breast cancer (TNBC). Furthermore, high burden of tumor cells may cause reduction of infiltrating CAR‐T cells and their functional exhaustion. In this study, various effector‐to‐target (E:T) ratio experiments are established to model the treatment using CAR‐T cells in leukemia (high E:T ratio) and solid tumor (low E:T ratio). It is found that the antitumor immune response is decreased in solid tumors with low E:T ratio. Furthermore, single cell sequencing is performed to investigate the functional exhaustion at a low ratio. It is revealed that the inhibition of mitophagy‐mediated mitochondrial dysfunction diminished the antitumor efficacy of CAR‐T‐cell therapy. The mitophagy agonist BC1618 is screened via AI‐deep learning and cytokine detection, in vivo and in vitro studies revealed that BC1618 significantly strengthened the antitumor response of CAR‐T cells via improving mitophagy. Here, injection hydrogels are engineered for the controlled co‐delivery of CAR‐T cells and BC1618 that improves the treatment of TNBC. Local delivery of hydrogels creates an inflammatory and mitophagy‐enhanced microenvironment at the tumor site, which stimulates the CAR‐T cells proliferation, provides antitumor ability persistently, and improves the effect of treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsMitophagyImmunotherapy, AdoptiveHydrogelsReceptors, Chimeric AntigenAnimalsHumansMiceFemaleCell Line, Tumor

Stichwörter der Autor:innen

CAR‐T‐cell therapyTNBChydrogel co‐deliverymitophagy agonistsingle cell sequencing

Substanzen

HydrogelsReceptors, Chimeric Antigen

Autor:innen und Institutionen

  • State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an, 710032, P. R. China.
  • Department of Thyroid, Breast, and Vascular Surgery, Xijing Hospital, The Air Force Medical University, Xi'an, P. R. China.
  • Hebei Provincial Cancer Institute, Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, P. R. China.
  • Center for Mitochondrial Biology and Medicine, The Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, 710049, P. R. Ch…
  • Bioinformatics Center of AMMS, Beijing, 100850, P. R. China.
  • Research Institution, Xijing hospital, The Fourth Military Medical University, Xi'an, 710032, P. R. China.

ORCID-Profile: Yuan Gao

Förderung

  • Shaanxi Science Fund for Distinguished Young Scholars
  • Nation Nature Science Foundation of China
  • Xijing Research Foundation
  • the Provincial Nature Science Foundation of Hebei
  • Medical Science Research Project of Healthy Commission of Hebei Province

Zitieren

APA

Li, G., Du, R., Wang, D., Zhang, X., Wang, L., Pu, S., Li, X., Wang, S., Zhang, J., Liu, B., Gao, Y., & Zhao, H. (2025). Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist. Advanced Science, 12(14). https://doi.org/10.1002/advs.202409835

Vancouver

Li G, Du R, Wang D, Zhang X, Wang L, Pu S, et al. Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist. Advanced Science. 2025;12(14). doi:10.1002/advs.202409835

BibTeX
@article{Li2025,
  author = {Li, Guodong and Du, Ruoxin and Wang, Donghui and Zhang, Xiangmei and Wang, Lizhuo and Pu, Shuangpeng and Li, Xiaoju and Wang, Shuning and Zhang, Juliang and Liu, Beichen and Gao, Yuan and Zhao, Huadong},
  title = {Improved Efficacy of Triple‐Negative Breast Cancer Immunotherapy via Hydrogel‐Based Co‐Delivery of CAR‐T Cells and Mitophagy Agonist},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {14},
  doi = {10.1002/advs.202409835}
}
Kostenlos starten →